Pentax Of America, Inc.

Pentax Of America, Inc. Pentax Medical Division, a foreign-owned manufacturer headquartered in Montvale, New Jersey, supplies specialized endoscopy equipment, video processors, scopes, and maintenance services to federal healthcare agencies as a prime contractor on full-and-open federal contracts, with no set-aside designations across its portfolio. The company operates primarily under NAICS 339112 (Surgical and Medical Instrument Manufacturing) and PSC 6525 (Imaging Equipment and Supplies), delivering concrete products such as video gastroscopes, colonoscopes, bronchoscopes, nasolaryngoscopes, digital capture systems, and EndoPro information management software to the Veterans Health Administration, Defense Health Agency, National Institutes of Health, and other civilian health agencies.

Pentax Medical's federal customer base concentrates heavily within the VA system. The top five customers by potential value account for 71% of combined potential value and are led by the Department of Veterans Affairs Veterans Integrated Service Network 12 (20 awards, $71.7 million combined potential value), followed by VISN 2 (83 awards, $19.4 million), VISN 22 (76 awards, $14.2 million), VISN 4 (36 awards, $8 million), and the Department of the Navy Bureau of Medicine and Surgery (141 awards, $7.9 million). By award count, the top five customers account for 30% of all awards, with the Navy placing the highest volume at 141 awards despite a relatively modest combined potential value of $7.9 million, whereas VISN 12 anchors the dollar value with only 20 awards. Defense Logistics Agency Troop Support Medical places 127 awards valued at $886 thousand, reflecting its high-volume, low-dollar consumables model (cleaning brushes, leak testers, ventilator components). The vendor has served 58 distinct federal agencies across its 1,604 prime awards.

Pentax Medical operates from two dominant contract vehicles. The Federal Supply Schedule V797P4389A carries 855 task orders valued at $45.9 million combined potential value, and the Medical Equipment and Supplies GSA Schedule (FSS-65-II-A) carries 166 task orders valued at $43.3 million. These two vehicles account for the vast majority of Pentax Medical's federal procurement footprint. Representative recent work includes a $3.67 million delivery order from VISN 2 for a five-year GI endoscope equipment and service lease at Buffalo VA Medical Center (awarded February 1, 2024, completion January 31, 2029), a $248.4 million delivery order from VISN 2 for Pentax endoscopic equipment (March 31, 2025), and a $1.19 million delivery order from VISN 4 for endoscopy equipment leasing and maintenance (December 1, 2021, completion October 31, 2024). Pentax Medical also supplies consumable medical items such as cleaning brushes and leak testers through standing purchase orders with the Defense Logistics Agency Medical Supply Chain and holds a $195.7 million annual software support agreement with Defense Health Agency for EndoPro information management software (awarded September 28, 2021, completion September 29, 2025).

Award velocity has remained steady over the past five years (16 awards in 2022, 17 in 2023, 17 in 2024, 13 in 2025, and 7 through June 2026), indicating consistent federal demand. Combined potential value across all 1,604 awards is $170.8 million, with $89.7 million obligated (53% of potential). However, the recompete exposure in the next twenty-four months is minimal — only four awards totaling $390 thousand reach ultimate completion, meaning Pentax Medical has limited large-contract expirations driving near-term recompete activity. The company's subcontractor footprint is negligible: only three sub-awards appear in the source, all to Cardinal Health 200, LLC for post-table retractor medical/surgical equipment (July and August 2022), reflecting Pentax Medical's predominantly prime-contractor posture. The company has maintained continuous federal contracting status since 2001 and consistently competes in full-and-open procurement, relying on its specialized endoscopy manufacturing capability and established GSA schedule position rather than set-aside categories.